Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer.

Hata M, Koike I, Miyagi E, Numazaki R, Asai-Sato M, Kasuya T, Kaizu H, Matsui T, Hirahara F, Inoue T.

Gynecol Oncol. 2013 Oct;131(1):99-102. doi: 10.1016/j.ygyno.2013.07.085. Epub 2013 Jul 19.

PMID:
23877014
2.

Radiation Therapy for Para-Aortic Lymph Node Metastasis from Uterine Cervical Cancer.

Hata M, Miyagi E, Koike I, Numazaki R, Asai-Sato M, Kasuya T, Kaizu H, Mukai Y, Hirahara F, Inoue T.

Anticancer Res. 2015 Sep;35(9):4849-54.

PMID:
26254377
3.

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG.

N Engl J Med. 1999 Apr 15;340(15):1137-43.

4.

Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.

Perez CA, Michalski J, Brown KC, Lockett MA.

Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):573-84.

PMID:
8948341
5.

Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer.

Wakatsuki M, Ohno T, Kato S, Ando K, Noda SE, Kiyohara H, Shibuya K, Karasawa K, Kamada T, Nakano T.

J Radiat Res. 2014 Jan 1;55(1):139-45. doi: 10.1093/jrr/rrt097. Epub 2013 Aug 2.

6.

Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.

Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P.

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):982-7.

PMID:
11704321
7.

Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.

Kim JY, Kim JY, Kim JH, Yoon MS, Kim J, Kim YS.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):741-7. doi: 10.1016/j.ijrobp.2012.01.070. Epub 2012 Aug 14.

PMID:
22898382
9.

Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.

Grigsby PW, Perez CA, Chao KS, Elbendary A, Herzog TJ, Rader JS, Mutch DG.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):645-51.

PMID:
10524418
10.

Pulsed low dose rate brachytherapy for uterine cervix carcinoma.

Rogers CL, Freel JH, Speiser BL.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):95-100.

PMID:
9989519
11.

Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.

Sood BM, Gorla G, Gupta S, Garg M, Deore S, Runowicz CD, Fields AL, Goldberg GL, Anderson PS, Vikram B.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):702-6.

PMID:
12062615
12.

Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases.

Cheng X, Cai SM, Li ZT, Wu XH, Ding YQ, Wang XE, Zang RY.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):779-84. Epub 2007 Oct 18.

PMID:
17944922
13.

Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.

Vargo JA, Kim H, Choi S, Sukumvanich P, Olawaiye AB, Kelley JL, Edwards RP, Comerci JT, Beriwal S.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1091-8. doi: 10.1016/j.ijrobp.2014.08.013. Epub 2014 Oct 8.

PMID:
25303889
14.

Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis.

Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Lee SP, Tseng CJ, Hsueh S.

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1284-90.

PMID:
12128131
15.

The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.

Yap ML, Cuartero J, Yan J, Pintilie M, Fyles A, Levin W, Manchul L, Milosevic M.

Clin Oncol (R Coll Radiol). 2014 Dec;26(12):797-803. doi: 10.1016/j.clon.2014.08.008. Epub 2014 Sep 4.

PMID:
25194726
16.

Is a low dose of concomitant chemotherapy with extended-field radiotherapy acceptable as an efficient treatment for cervical cancer patients with metastases to the para-aortic lymph nodes?

Kazumoto T, Kato S, Yokota H, Hasumi Y, Kino N, Horie K, Yoshida D, Mizukami T, Saito Y.

Int J Gynecol Cancer. 2011 Nov;21(8):1465-71. doi: 10.1097/IGC.0b013e318226f657.

PMID:
21892097
17.

High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.

Kim YS, Kim JH, Ahn SD, Lee SW, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1522-8. doi: 10.1016/j.ijrobp.2008.10.024. Epub 2009 Feb 21.

PMID:
19231106
18.

Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.

Uno T, Ito H, Itami J, Yasuda S, Isobe K, Hara R, Sato T, Minoura S, Shigematsu N, Kubo A.

Anticancer Res. 2000 May-Jun;20(3B):2235-9.

PMID:
10928184
19.

Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.

Kim JS, Kim JS, Kim SY, Kim Ki, Cho MJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1247-53. Review.

PMID:
12654434
20.

Postoperative radiation for cervical cancer with pathologic risk factors.

Hart K, Han I, Deppe G, Malviya V, Malone J Jr, Christensen C, Chuba P, Porter A.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):833-8.

PMID:
9128959

Supplemental Content

Support Center